Cargando…
Blood Component Recalls and Market Withdrawals: Frequency, Reasons, and Management in the United States
In a previous article, we reviewed the management of blood component recalls and withdrawals (G. Ramsey. Transfusion Med Rev 2004;18:36–45). Since then, US rates of recall and biological product deviation for blood components have improved significantly, particularly with regard to reduced recalls f...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127789/ https://www.ncbi.nlm.nih.gov/pubmed/23375736 http://dx.doi.org/10.1016/j.tmrv.2012.11.001 |